The Nobel prize for Physiology to two stem cell research scientists in 2012 has firmly put the spotlight on this promisi...
Singapore: Australian firm Prima BioMed suggested several changes to its senior management and its board of directors, w...
Thanks to the Human Genome Project, scientists now have a set of tools that can be readily used to understand the comple...
Singapore: A new therapy to treat a common hospital superbug infection Clostridium difficile will soon be available to A...
Singapore: Australia based Admedus has received FDA clearance to market CardioCel in the US. CardioCel is the group's l...
Singapore: Biolife Science's strategy of targeting the tumour-associated antigen HER-2/NEU has been the focus of a recen...
Biologics manufacturers in Asia have to be more vigilant and give higher priority to product safety and product efficacy...
Singapore: The Supreme Court of Victoria, Australia, has ordered a meeting of Biota Holdings shareholders to consider an...
Singapore: Viralytics reported strong interim results from its phase II clinical trial of Cavatak treatment in late stag...
Singapore: Researchers in Monash University, Australia, have found prostate cancer cells that survive androgen withdrawa...
Singapore: The global pre-diabetes population is three times the size of the current diabetes patient population and the...
A radical shift in how healthcare is delivered globally is underway. Game-changing developments in sensor technologies w...
Singapore: Phylogica has received a core patent in Australia (Registration no: 2009251209; Divisional of AU 2008200790)...
Singapore: In a bid to shift its focus from technology development to sales, Australia's top medical device manufacturer...
Singapore: In a move to venture into the global market, Australia's leading healthcare logistics provider STL Warehousin...
Singapore: GI Dynamics received conditional approval from the US FDA to commence a pivotal clinical trial of the EndoBar...
The pioneering research of Nobel Laureates Sir John Gurdon and Dr Shinya Yamanaka on reprogramming adult stem cells has ...
Singapore: Takeda Global Research and Development, a wholly owned subsidiary of Takeda Pharmaceutical, has filed seven n...
